Literature DB >> 23278679

Molecular investigation of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa isolated clinically in Thailand.

Piyatip Khuntayaporn1, Preecha Montakantikul, Pitak Santanirand, Pattarachai Kiratisin, Mullika Traidej Chomnawang.   

Abstract

Carbapenem resistant Pseudomonas aeruginosa were isolated among multidrug-resistant (CR-MDR) organisms from tertiary hospitals in Thailand. Decreased expression of oprD mRNA (93.65%) was predominant followed by increased expression of mexAB-oprM mRNA (92.06%) and mexXY mRNA (63.49%). Interestingly, 23 of 126 (18.25%) isolates were susceptible to imipenem with down-regulated oprD expression and non-up-regulated mexCD-oprJ mRNA expression. Metallo-β-lactamases production was clearly positive in 24 isolates (18.46%) and weakly positive in 12 isolates (9.23%). Among both of these sets of isolates, imp-1, imp-14 and vim-2 were identified. Hyperproduction of AmpC β-lactamase had the lowest prevalence rate (3.97%). It was concluded that CR-MDR P. aeruginosa clinical isolates in Thailand possess multifactorial resistance mechanisms.
© 2012 The Societies and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23278679     DOI: 10.1111/1348-0421.12021

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  13 in total

1.  AcGI1, a novel genomic island carrying antibiotic resistance integron In687 in multidrug resistant Achromobacter xylosoxidans in a teaching hospital in Thailand.

Authors:  Pisut Pongchaikul; Pitak Santanirand; Svetlana Antonyuk; Craig Winstanley; Alistair C Darby
Journal:  FEMS Microbiol Lett       Date:  2020-07-01       Impact factor: 2.742

2.  Persistence of Pseudomonas aeruginosa in a pulmonary nodule with late relapse.

Authors:  S Ronkainen; Y Xie; M Battiwalla; A J Barrett; F Stock; J P Dekker; R L Danner
Journal:  Transpl Infect Dis       Date:  2014-06-26       Impact factor: 2.228

3.  Berberine inhibits the MexXY-OprM efflux pump to reverse imipenem resistance in a clinical carbapenem-resistant Pseudomonas aeruginosa isolate in a planktonic state.

Authors:  Fen Su; Jiliang Wang
Journal:  Exp Ther Med       Date:  2017-11-01       Impact factor: 2.447

4.  Efflux-mediated fluoroquinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operon.

Authors:  Yuji Morita; Junko Tomida; Yoshiaki Kawamura
Journal:  Front Microbiol       Date:  2015-01-21       Impact factor: 5.640

5.  First Report of blaIMP-14 on a Plasmid Harboring Multiple Drug Resistance Genes in Escherichia coli Sequence Type 131.

Authors:  Nicole Stoesser; Anna E Sheppard; Gisele Peirano; Robert P Sebra; Tarah Lynch; Luke W Anson; Andrew Kasarskis; Mary R Motyl; Derrick W Crook; Johann D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

6.  Molecular epidemiological survey of bacteremia by multidrug resistant Pseudomonas aeruginosa: the relevance of intrinsic resistance mechanisms.

Authors:  Raquel Cristina Cavalcanti Dantas; Rebecca Tavares E Silva; Melina Lorraine Ferreira; Iara Rossi Gonçalves; Bruna Fuga Araújo; Paola Amaral de Campos; Sabrina Royer; Deivid William da Fonseca Batistão; Paulo Pinto Gontijo-Filho; Rosineide Marques Ribas
Journal:  PLoS One       Date:  2017-05-08       Impact factor: 3.240

Review 7.  Prevalence of Clinically Isolated Metallo-beta-lactamase-producing Pseudomonas aeruginosa, Coding Genes, and Possible Risk Factors in Iran.

Authors:  Abdolmajid Ghasemian; Kobra Salimian Rizi; Hassan Rajabi Vardanjani; Farshad Nojoomi
Journal:  Iran J Pathol       Date:  2018

8.  Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia.

Authors:  Nuntra Suwantarat; Karen C Carroll
Journal:  Antimicrob Resist Infect Control       Date:  2016-05-04       Impact factor: 4.887

9.  Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections.

Authors:  Nattawan Palavutitotai; Anupop Jitmuang; Sasima Tongsai; Pattarachai Kiratisin; Nasikarn Angkasekwinai
Journal:  PLoS One       Date:  2018-02-22       Impact factor: 3.240

10.  Carbapenem-Resistant but Cephalosporin-Susceptible Pseudomonas aeruginosa in Urinary Tract Infections: Opportunity for Colistin Sparing.

Authors:  Márió Gajdács
Journal:  Antibiotics (Basel)       Date:  2020-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.